Cargando…
Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials
BACKGROUND: The use of health-related quality of life (HRQoL) as an endpoint in cancer clinical trials is growing rapidly. Hence, research into the statistical approaches used to analyze HRQoL data is of major importance, and could lead to a better understanding of the impact of treatments on the ev...
Autores principales: | Barbieri, Antoine, Peyhardi, Jean, Conroy, Thierry, Gourgou, Sophie, Lavergne, Christian, Mollevi, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615461/ https://www.ncbi.nlm.nih.gov/pubmed/28950850 http://dx.doi.org/10.1186/s12874-017-0410-9 |
Ejemplares similares
-
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials
por: Touraine, Célia, et al.
Publicado: (2023) -
Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study
por: Anota, Amélie, et al.
Publicado: (2014) -
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients
por: Anota, Amélie, et al.
Publicado: (2014) -
Comment on “Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial”: The RAPIDO Trial Does Not Achieve Its Primary Endpoint
por: Riou, Olivier, et al.
Publicado: (2023) -
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17
por: Cuer, B., et al.
Publicado: (2020)